Klein, Roger D.
Hultgren, Scott J. http://orcid.org/0000-0001-8785-564X
Article History
Accepted: 7 January 2020
First Online: 18 February 2020
Competing interests
: S.J.H. has an ownership interest in Fimbrion Therapeutics, and may benefit if the company is successful in marketing mannosides. S.J.H. is also the chief scientific officer of QureTech Bio. R.D.K. declares no competing interests.